bis zum Handelsschluß liegt wahrscheinlich noch mehr drin bei dem Volumen.  

 

Calypte Announces License From CDC for HIV Incidence Test
4/12/2004 9:06:00 AM


ALAMEDA, Calif., Apr 12, 2004 /PRNewswire-FirstCall via COMTEX/ -- Calypte Biomedical Corporation (CYPT) , a company engaged in developing rapid tests for HIV diagnosis and the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA-approved serum HIV-1 antibody Western Blot supplemental test, announced today that the Centers for Disease Control and Prevention (CDC) has granted Calypte a worldwide, non-exclusive license enabling Calypte to use technologies developed by the CDC to manufacture and commercialize a serum enzyme immunoassay (HIV1 -EIA) that can be used to estimate the proportion of HIV infections that are recently acquired in a population (infections occurring in the last 6-8 months). Included in the license are rights to use the proprietary synthetic peptide antigen (called the BED antigen) based on sequences from the immunodominant region of the glycoprotein gp41 of multiple subtypes of HIV-1.

The HIV-1 incidence test has been the subject of numerous publications describing its usefulness as an epidemiological measurement to track the expansion of the HIV pandemic into susceptible populations. The laboratory assays can be used to identify those regions and the populations within those regions where HIV transmission is occurring most recently. This knowledge will allow prevention resources to be focused on programs that have been shown to be effective. The HIV-1 EIA is currently made by the CDC and is currently being validated in a number of public health laboratories worldwide as part of the Serologic Testing Algorithm for Recent HIV Seroconversion (STARHS). Data collected to date is encouraging for the surveillance use of this assay and final evaluation and validation is expected to be completed in the next few months. Once Calypte's production capabilities are in place, the CDC will no longer supply this product.

According to Dr. Richard George, President and CEO of Calypte, "The use of serologic assays to estimate HIV incidence has been used for some time and has been proven to be an effective tool in identifying populations most at risk for HIV. It will allow Public Health agencies to more efficiently use their resources by focusing their efforts on those groups having the greatest need using programs that are effective for that particular risk group."

Tony Cataldo, Executive Chairman of Calypte, stated "The amount of funding being made available to identify and treat HIV infected people is unprecedented. Calypte is very pleased to be able to assist the CDC in making this valuable assay more available to those countries where HIV infection is endemic. We expect that the efficiencies resulting from the consolidation of our manufacturing operations at our Rockville, Maryland facility will enable us to provide a stable, high-quality supply of this test for the foreseeable future, and that its availability will allow more efficient use of the money now being granted to countries around the world to fight HIV and AIDS."

About Calypte Biomedical:

Calypte Biomedical Corporation, headquartered in Alameda, California, is a public healthcare company dedicated to the development and commercialization of in vitro diagnostic tests, primarily for the detection of antibodies to Human Immunodeficiency Virus (HIV), and other sexually transmitted and infectious diseases. Calypte's currently marketed laboratory-based tests include an enzyme immunoassay (EIA) HIV-1 antibody screening test and an HIV-1 antibody western blot supplemental test, the only two FDA-approved HIV-1 antibody tests for use on urine samples, as well as an FDA-approved serum HIV- 1 antibody western blot supplemental test. Calypte is actively engaged in developing new test products for the rapid detection of HIV and other infectious diseases. Calypte believes that there is a significant need for rapid detection of such diseases globally to control their proliferation, particularly in lesser-developed countries, which lack the medical infrastructure to support laboratory-based testing. Calypte believes that testing for HIV and other infectious diseases may make important contributions to public health.

Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, the Company's ability to obtain additional financing and access funds from its existing financing arrangements that will allow it to continue its current and future operations and whether demand for its test products in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-KSB for the year ended December 31, 2003 and its subsequent filings with the SEC.

    Company Contact:
    Dr. J. Richard George, President and CEO
    (510) 749-5100
    email: rgeorge@calypte.com

    Investor Relations Contact:
    Tim Clemensen
    Rubenstein Investor Relations
    Phone: 212-843-9337
    Email: tclemensen@rubensteinir.com


SOURCE Calypte Biomedical Corporation

Dr. J. Richard George, President and CEO, Calypte Biomedical
Corporation, +1-510-749-5100, rgeorge@calypte.com; or Investor Relations - Tim
Clemensen, Rubenstein Investor Relations, +1-212-843-9337,
tclemensen@rubensteinir.com, for Calypte


 

Ridgeland, MS, APR 12, 2004 (EventX/Knobias.com über COMTEX) -- Calypte Biomedical Corporation (CYPT) verkündete, daß die Mitten zur Krankheit-Steuerung und zur Verhinderung (CDC) Calypte eine weltweite bewilligt hat, nicht-exklusive Lizenz, Calypte ermöglichend, die Technologien zu verwenden, die durch die CDC entwickelt werden, um ein immunoassay Serumenzym herzustellen und in den Handel zu bringen (HIV1 - EIA) das verwendet werden kann, um den Anteil HIV Infektion zu schätzen, die vor kurzem in einer Bevölkerung erworben werden (die Infektion, die in den letzten 6-8 Monaten auftritt). In der Lizenz geschlossen Rechte, das eigene synthetische Peptidantigen zu benutzen (genannt das BETT-Antigen) basiert auf Reihenfolgen von der immunodominant Region des Glucoproteids gp41 der mehrfachen Formationsglieder von HIV-1 ein.

12:41:38    0.630 500 OTC BBS  
12:37:19    0.630 1000 OTC BBS  
12:35:19    0.630 4400 OTC BBS  
12:32:46    0.630 1000 OTC BBS  
12:32:39    0.630 10000 OTC BBS  
12:30:47    0.630 9000 OTC BBS  
12:30:09    0.630 300 OTC BBS  
12:29:17    0.630 1000 OTC BBS  
12:29:12    0.640 26500 OTC BBS  
12:28:57    0.630 400 OTC BBS
 

was ist so toll an der Nachricht?
abwarten...  

Calypte um +12,5 % steigen ließen.

Gruß Kade_I  

das ist es ja, 12% oh wie toll..und das an der OTC, ich bin begeistert....und die Lemminge in Deutschland laufen morgen zu überteuerten Preisen hinterher und werden ab 15.30h eines Besseren belehrt.

Und jetzt sag du mir bitte was an der News so toll für dich war, ja ich meine dich, deine Meinung, deine Interpretation!

Bitte höflichst um Antwort

greetz
Jovi  

Zeit zu nehmen und die News für Dich auseinander zu nehmen. Les doch selbst. Das ist sicher nicht die BIG NEWS mit der ich noch rechne, aber sicher eine wichtige auf dem Weg zur eigenständigen Vermarktung von Calyptes HIV I und II - Rapid-Testkits. Es ist noch gar nicht lange her, da haben einige Calyptes Zukunft in Frage gestellt, da Calypte ja nicht mal die notwendigen Rechte und Patente für den Rapidtest habe. Und nun ? Ist´s auch wieder nicht gut. Was willste denn für ne NEWS ? Vielleicht Calypte Großauftrag in Rußland ? Kannste vielleicht bald haben ! Dann ist Caly aber 2$+ Wert.

Außerdem dachte ich gelesen zu haben, dass Du ein alter OTC-Veteran bist. Dann solltest Du aber auch wissen, dass es dort NICHT an der Tagesordnung ist, dass ein Wert nach einer NEWS mal schnell um mehrere 100% nach oben geht. Gibts manchmal, aber selten. Sonst wäre ja alle Welt nur in OTC-Werten.

Geduld, Calypte ist auf dem richtigen Weg - wenn Du nicht dieser Meinung bist, ist das doch völlig OK. Jeder sollte in das investieren an das er glaubt- und das ist bei mir Caly !

Grüße Kade_I  

Investierten !!  Ich grüße euch  !!

Ich war wohl etwas früh drann mit meiner Prognose und habe auch momentan wenig Zeit zum Posten sonst hätte ich mich schon mal öfter gemeldet .

Aber deine Aussage trifft den Kern , so sehe ich das auch Kade wenngleich man bedenken muß , das wenn die richtig guten News kommen ist es evtl. noch nicht zu spät zum einsteigen - aber dieser Artikel lässt für morgen einen schönen Spielraum zum Daytraden !

Gruß
leo  

 

"les doch selber" ---  das können einige anscheinend nicht !!

bei Ariva  wird vielzuviel über Fakten gelabert die einmal als News kommen , aber dann in einigen Monaten immer wieder zur Argumentation herangezogen werden --  sind aber News da , sind es nicht die erhofften -- toll °!

über News sollte man reden / Gedankenaustausch pflegen / sich eine Meinung über den Kursverlauf bilden und gut .

Sonst haben wir bald nur noch WCM auf dem Board !

was übrigens nichts mit dem Posting von Jovi zutun hat / das mache ich auch , solche Traydingchancen versuchen zu nutzen !

Gruß
leo  

ich hör ja schon auf.
Mal schaun wie der Weg weiter geht.
Ich wünsche allen einen erfolgreichen Tag und fette Gewinne.

Gruß an alle
Jovi  

Bin wieder zurück aus dem Eier-We. ;O). Und was sehen meine Augen? Schöne Sache. Tja, bin mal gespannt, was manche sagen, wenn wirklich gute News kommen. Wahrscheinlich reden sie wieder vom Strohfeuer und das Caly die Leute veräppelt und Mar stößt seine Pakete bald ab und, und, und ......Ich glaubs nicht. Und selbst, wenn Caly es nicht schafft, es macht Spaß Caly im Depot zu haben und auch wenn es Zweifler gibt, kann keiner von ihnen sagen, der Wert hätte keine Fantasie. In diesem Sinne: auf die Fantasie und das sie Caly weiter Auftrieb gibt.  

 

Trade Zeit Kurs Volumen
n/a    15:46:26    0.57    2'900  
n/a    15:46:11    0.57    150  
n/a    15:45:30    0.56    4'000  
n/a    15:45:21    0.57    2'500  
n/a    15:43:23    0.57    800  
n/a    15:43:09    0.57    900  
n/a    15:43:03    0.57    1'500  
n/a    15:43:01    0.58    3'000  
n/a    15:42:38    0.58    6'000  
n/a    15:42:09    0.57    1'000  
n/a    15:42:05    0.57    2'500  
n/a    15:41:49    0.57    5'000  
n/a    15:41:37    0.58    2'500  
n/a    15:41:36    0.58    2'500  
n/a    15:41:36    0.59    1'000  
n/a    15:41:36    0.59    1'500  
n/a    15:41:34    0.58    2'500  
n/a    15:39:51    0.6    1'000  
n/a    15:39:51    0.6    830  
n/a    15:39:51    0.6    2'000  
n/a    15:39:12    0.6    1'000  
n/a    15:39:08    0.6    1'000  
n/a    15:38:33    0.6    10'000  
n/a    15:38:21    0.595    10'000  
n/a    15:38:14    0.5    200  
n/a    15:38:13    0.595    2'500  
n/a    15:37:31    0.5    1'000  
n/a    15:37:27    0.6    10'000  
n/a    15:37:26    0.6    5'750  
n/a    15:37:01    0.6    2'500  
n/a    15:37:00    0.6    12'500  
n/a    15:36:54    0.6    2'500  
n/a    15:36:23    0.605    500  
n/a    15:36:23    0.605    1'000  
n/a    15:36:23    0.605    1'000  
n/a    15:36:23    0.605    3'600  
n/a    15:35:44    0.6    1'000  
n/a    15:35:13    0.6    2'500  
n/a    15:35:12    0.605    2'500  
n/a    15:34:48    0.61    4'000  
n/a    15:34:47    0.6    4'000  
n/a    15:34:45    0.605    500  
n/a    15:33:18    0.6    1'000  
n/a    15:33:16    0.62    967  
n/a    15:30:45    0.61    500  
n/a    15:30:45    0.61    1'000  
n/a    15:30:41    0.61    400  
n/a    15:30:41    0.61    600  
n/a    15:30:37    0.62    500  
n/a    15:30:35    0.62    1'000  
n/a    15:30:34    0.61    1'500  
n/a    15:30:32    0.62    400  
n/a    15:30:32    0.62    600  
n/a    15:30:30    0.61    1'000  
n/a    15:30:29    0.6    7'400  
n/a    15:30:25    0.62    1'000  
n/a    15:30:19    0.62    15'000  
n/a    15:30:16    0.62    21'000  
n/a    15:30:08    0.6    4'000  
n/a    15:30:06    0.62    1'000  
n/a    15:30:05    0.62    1'000  
n/a    15:30:04    0.62    4'000  
n/a    15:30:04    0.6    6'000  
 

bei caly aus - hat wer RT´s??

danke  

aber heut ist ja dienstag = newstag *gg*  

 

15:54:30    0.55    8'001  
n/a    15:54:24    0.555    5'000  
n/a    15:53:32    0.55    3'000  
n/a    15:53:29    0.55    2'500  
n/a    15:52:58    0.55    1'999  
n/a    15:48:28    0.55    3'630  
n/a    15:47:51    0.55    2'500  
n/a    15:47:18    0.55    7'500  
n/a    15:47:13    0.56    2'500  
n/a    15:46:56    0.56    10'000  
n/a    15:46:55    0.56    2'500  
n/a    15:46:49    0.57    2'600  
n/a    15:46:49    0.57    8'500  
n/a    15:46:27    0.57    2'900  
n/a    15:46:11    0.57    150  
n/a    15:45:30    0.56    4'000  
n/a    15:45:21    0.57    2'500  
n/a    15:43:23    0.57    800  
n/a    15:43:09    0.57    900  
n/a    15:43:03    0.57    1'500  
n/a    15:43:01    0.58    3'000  
n/a    15:42:38    0.58    6'000  
n/a    15:42:09    0.57    1'000  
n/a    15:42:05    0.57    2'500  
n/a    15:41:49    0.57    5'000  
n/a    15:41:37    0.58    2'500  
n/a    15:41:36    0.58    2'500  
n/a    15:41:36    0.59    1'000  
n/a    15:41:36    0.59    1'500  
n/a    15:41:34    0.58    2'500  
n/a    15:39:51    0.6    1'000  
n/a    15:39:51    0.6    830  
n/a    15:39:51    0.6    2'000  
n/a    15:39:12    0.6    1'000  
n/a    15:39:08    0.6    1'000  
n/a    15:38:33    0.6    10'000  
n/a    15:38:21    0.595    10'000  
n/a    15:38:14    0.5    200  
n/a    15:38:13    0.595    2'500  
n/a    15:37:31    0.5    1'000  
n/a    15:37:27    0.6    10'000  
n/a    15:37:26    0.6    5'750  
n/a    15:37:01    0.6    2'500  
n/a    15:37:00    0.6    12'500  
n/a    15:36:54    0.6    2'500  
n/a    15:36:23    0.605    500  
n/a    15:36:23    0.605    1'000  
n/a    15:36:23    0.605    1'000  
n/a    15:36:23    0.605    3'600  
n/a    15:35:44    0.6    1'000  
n/a    15:35:13    0.6    2'500  
n/a    15:35:12    0.605    2'500  
n/a    15:34:48    0.61    4'000  
n/a    15:34:47    0.6    4'000  
n/a    15:34:45    0.605    500  
n/a    15:33:18    0.6    1'000  
n/a    15:33:16    0.62    967  
n/a    15:30:45    0.61    500  
n/a    15:30:45    0.61    1'000  
n/a    15:30:41    0.61    400  
n/a    15:30:41    0.61    600  
n/a    15:30:37    0.62    500  
n/a    15:30:35    0.62    1'000  
n/a    15:30:34    0.61    1'500  
n/a    15:30:32    0.62    400  
n/a    15:30:32    0.62    600  
n/a    15:30:30    0.61    1'000  
n/a    15:30:29    0.6    7'400  
n/a    15:30:25    0.62    1'000  
n/a    15:30:19    0.62    15'000  
n/a    15:30:16    0.62    21'000  
n/a    15:30:08    0.6    4'000  
n/a    15:30:06    0.62    1'000  
n/a    15:30:05    0.62    1'000  
n/a    15:30:04    0.62    4'000  
n/a    15:30:04    0.6    6'000  





 

http://bigcharts.marketwatch.com/quickchart/...freq=6&time=2&x=33&y=9

war nur kurz... Tagestief 0,50 $  

 

verkauf, arme sau.... LOL  

n/a    16:10:04    0.545    2'000  
n/a    16:08:45    0.545    1'050  
n/a    16:06:21    0.545    17'500  
n/a    16:05:43    0.545    50'000  
n/a    16:05:06    0.545    500  
n/a    16:04:41    0.55    722  
n/a    16:02:24    0.545    5'000  
n/a    16:01:49    0.545    2'500  
n/a    16:01:44    0.545    1'500  
n/a    16:01:42    0.55    2'500  
n/a    16:01:42    0.55    10'500  
n/a    16:01:40    0.545    2'500  
n/a    16:01:10    0.545    700  
n/a    16:00:52    0.55    1'960  
n/a    16:00:39    0.55    7'500  
n/a    16:00:39    0.545    25'000  
n/a    16:00:10    0.545    1'000  
n/a    15:59:06    0.545    2'500  
n/a    15:58:56    0.55    2'000  
n/a    15:58:27    0.55    5'000  
n/a    15:57:55    0.55    2'500  
n/a    15:57:50    0.55    2'500  
n/a    15:57:44    0.55    10'000  
n/a    15:57:34    0.55    2'500  
n/a    15:54:30    0.55    8'001  
n/a    15:54:24    0.555    5'000  
n/a    15:53:32    0.55    3'000  
n/a    15:53:29    0.55    2'500  
n/a    15:52:58    0.55    1'999  
n/a    15:48:28    0.55    3'630  
n/a    15:47:51    0.55    2'500  
n/a    15:47:18    0.55    7'500  
n/a    15:47:13    0.56    2'500  
n/a    15:46:56    0.56    10'000  
n/a    15:46:55    0.56    2'500  
n/a    15:46:49    0.57    2'600  
n/a    15:46:49    0.57    8'500  
n/a    15:46:27    0.57    2'900  
n/a    15:46:11    0.57    150  
n/a    15:45:30    0.56    4'000  
n/a    15:45:21    0.57    2'500  
 

zumindest so aus.;O)  

vorher 0,54 !!!